This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Dec;38(12):6347-50.

doi: 10.1118/1.3639137.

Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process

David J Carlson¹, Kamil M Yenice, Colin G Orton

Affiliations

PMID: 22149817
DOI: 10.1118/1.3639137

Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process

David J Carlson et al. Med Phys. 2011 Dec.

. 2011 Dec;38(12):6347-50.

doi: 10.1118/1.3639137.

Authors

David J Carlson¹, Kamil M Yenice, Colin G Orton

Affiliation

¹ Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA. david.j.carlson@yale.edu

PMID: 22149817
DOI: 10.1118/1.3639137

No abstract available

PubMed Disclaimer

Similar articles

Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
Stavreva NA, Warkentin B, Stavrev PV, Fallone BG. Stavreva NA, et al. Med Phys. 2005 Mar;32(3):720-5. doi: 10.1118/1.1861523. Med Phys. 2005. PMID: 15839343
Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
Selvaraj J, Uzan J, Baker C, Nahum A. Selvaraj J, et al. Med Phys. 2013 Apr;40(4):041715. doi: 10.1118/1.4795131. Med Phys. 2013. PMID: 23556885
Biological dose volume histograms during conformal hypofractionated accelerated radiotherapy for prostate cancer.
Koukourakis MI, Abatzoglou I, Touloupidis S, Manavis I. Koukourakis MI, et al. Med Phys. 2007 Jan;34(1):76-80. doi: 10.1118/1.2401655. Med Phys. 2007. PMID: 17278492
Planning in the IGRT context: closing the loop.
Mageras GS, Mechalakos J. Mageras GS, et al. Semin Radiat Oncol. 2007 Oct;17(4):268-77. doi: 10.1016/j.semradonc.2007.06.002. Semin Radiat Oncol. 2007. PMID: 17903704 Review.
Toward a New Framework for Clinical Radiation Biology.
Willers H, Keane FK, Kamran SC. Willers H, et al. Hematol Oncol Clin North Am. 2019 Dec;33(6):929-945. doi: 10.1016/j.hoc.2019.07.001. Epub 2019 Sep 17. Hematol Oncol Clin North Am. 2019. PMID: 31668212 Review.

See all similar articles

Cited by

The Reciprocity between Radiotherapy and Cancer Immunotherapy.
Wang Y, Liu ZG, Yuan H, Deng W, Li J, Huang Y, Kim BYS, Story MD, Jiang W. Wang Y, et al. Clin Cancer Res. 2019 Mar 15;25(6):1709-1717. doi: 10.1158/1078-0432.CCR-18-2581. Epub 2018 Nov 9. Clin Cancer Res. 2019. PMID: 30413527 Free PMC article. Review.
Impact of dietary ingredients on radioprotection and radiosensitization: a comprehensive review.
Islam MM, Sultana N, Liu C, Mao A, Katsube T, Wang B. Islam MM, et al. Ann Med. 2024 Dec;56(1):2396558. doi: 10.1080/07853890.2024.2396558. Epub 2024 Sep 25. Ann Med. 2024. PMID: 39320122 Free PMC article. Review.
Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.
Cheng CC, Guan SS, Yang HJ, Chang CC, Luo TY, Chang J, Ho AS. Cheng CC, et al. J Biomed Sci. 2016 Jan 28;23:18. doi: 10.1186/s12929-016-0219-6. J Biomed Sci. 2016. PMID: 26822586 Free PMC article.
Multi-parametric MRI for radiotherapy simulation.
Li T, Wang J, Yang Y, Glide-Hurst CK, Wen N, Cai J. Li T, et al. Med Phys. 2023 Aug;50(8):5273-5293. doi: 10.1002/mp.16256. Epub 2023 Feb 9. Med Phys. 2023. PMID: 36710376 Free PMC article. Review.
New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg' effect discovery.
Mireștean CC, Iancu RI, Iancu DPT. Mireștean CC, et al. Front Oncol. 2022 Dec 8;12:908695. doi: 10.3389/fonc.2022.908695. eCollection 2022. Front Oncol. 2022. PMID: 36568220 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley